Hand, Foot and Mouth Disease Drugs in Development: 2021 Pipeline Guide on Therapeutics Under Development - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hand, Foot and Mouth Disease (Infectious Disease) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering.

The Pharmaceutical and Healthcare disease pipeline guide provides an overview of the Hand, Foot and Mouth Disease (Infectious Disease) pipeline landscape.

Hand, foot and mouth disease is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease (HFMD) is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite and ulcers in the throat (including tonsils), mouth, and tongue. Treatment includes antibiotics and pain relievers.

Report Highlights:

The pipeline guide provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The pipeline guide also reviews key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed and Preclinical stages are 1, 2, 1 and 6 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 5 molecules, respectively.

Report Scope:

• The pipeline guide provides a snapshot of the global therapeutic landscape of Hand, Foot and Mouth Disease (Infectious Disease).
• The pipeline guide reviews pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Hand, Foot and Mouth Disease (Infectious Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Hand, Foot and Mouth Disease (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease)

Key Topics Covered:

Hand, Foot and Mouth Disease - Overview

• Hand, Foot and Mouth Disease - Therapeutics Development

Pipeline Overview

• Pipeline by Companies
• Pipeline by Universities/Institutes
• Products under Development by Companies
• Products under Development by Universities/Institutes

Hand, Foot and Mouth Disease - Therapeutics Assessment

Hand, Foot and Mouth Disease - Companies Involved in Therapeutics Development

• Adimmune Corp
• AIM Vaccine Co Ltd
• Beijing Minhai Biotechnology Co Ltd
• Changchun Bcht Biotechnology Co Ltd
• Chongqing Zhifei Biological Products Co Ltd
• Emergex Vaccines Holding Ltd
• HK inno.N Corp
• Sentinext Therapeutics Sdn Bhd
• Shanghai Zerun Biotechnology Co Ltd

Hand, Foot and Mouth Disease - Drug Profiles

• (coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine - Drug Profile
• B-1108 - Drug Profile
• CJ-40010 - Drug Profile
• D-5 - Drug Profile
• DC-07090 - Drug Profile
• DMA-135 - Drug Profile
• E-71 - Drug Profile
• enterovirus [serotype 71] (virus like particle) vaccine - Drug Profile
• Enterovirus [serotype EV-71/C4] vaccine - Drug Profile
• Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile
• Enterovirus [serotype EV-A71] vaccine - Drug Profile
• hand, foot and mouth disease (bivalent) vaccine - Drug Profile
• hand, foot and mouth disease vaccine - Drug Profile
• Monoclonal Antibody for Hand, Foot and Mouth Disease - Drug Profile
• Small Molecules for Hand, Foot and Mouth Disease - Drug Profile
• Small Molecules for Hand, Foot and Mouth Disease (HFMD) - Drug Profile
• Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease - Drug Profile
• STX-100 - Drug Profile

Hand, Foot and Mouth Disease - Dormant Projects

Hand, Foot and Mouth Disease - Discontinued Products

For more information about this report visit https://www.researchandmarkets.com/r/ittcpa

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900